Insulet
PODD
#1347
Rank
NZ$28.47 B
Marketcap
NZ$404.59
Share price
-2.89%
Change (1 day)
-17.72%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: NZ$28.47 Billion

As of February 2026 Insulet has a market cap of NZ$28.47 Billion. This makes Insulet the world's 1347th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$28.47 B-18.82%
2025NZ$35.08 B6.39%
2024NZ$32.97 B37.63%
2023NZ$23.95 B-25.6%
2022NZ$32.20 B19.86%
2021NZ$26.86 B15.02%
2020NZ$23.35 B46.58%
2019NZ$15.93 B127.67%
2018NZ$6.99 B23.81%
2017NZ$5.65 B80.97%
2016NZ$3.12 B-0.72%
2015NZ$3.14 B-4.93%
2014NZ$3.30 B33.6%
2013NZ$2.47 B98.59%
2012NZ$1.24 B9.09%
2011NZ$1.14 B25.25%
2010NZ$0.91 B22.99%
2009NZ$0.74 B117.68%
2008NZ$0.34 B-56.6%
2007NZ$0.78 B

End of Day market cap according to different sources

On Feb 21st, 2026 the market cap of Insulet was reported to be:

NZ$28.46 Billion
by Nasdaq info icon info icon
NZ$28.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$977.42 B 3,332.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$326.65 B 1,046.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$207.79 B 629.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$1.592 T 5,493.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ$2.78 B-90.22%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$6.48 B-77.23%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$47.67 B 67.39%๐Ÿ‡บ๐Ÿ‡ธ USA